Preventicus
PrivateLast Round
Early Funding
Dec 15, 2020
Total Funding Raised
$4.74M
Company Overview
Preventicus operates in Healthcare & Life Sciences and is based in Jena. Its latest recorded funding round was an Early Funding round in December 2020.
Preventicus is a healthcare technology company that develops a digital health platform designed for the early preclinical risk screening of illnesses such as heart attacks and strokes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Telemedicine, Health IoT, InsurTech
Business Model
B2B2C
Customer Profile
Government Contracts, Subscription SaaS, Freemium, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Preventicus Comparables
Compare Preventicus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qompium | 90% | |
| CardioSignal | 84% | |
| Happitech | 78% |
For institutional investors. Book with your work email.
Preventicus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Dec 15, 2020 | ||||
| Grant | Jun 1, 2019 | ||||
| Grant | Nov 1, 2018 | ||||
| Seed | Oct 6, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Preventicus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Privegest SA | Early Funding |
| BORN2GROW | Series A |
| Born2grow | Seed |
| European Commission | Grant |
| Cascara Ventures | Series A |
| bm|t beteiligungsmanagement thüringen | Series A, Early Funding |
| High-Tech Gründerfonds | Seed |
Preventicus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Preventicus's valuation, stock price, and market status.
Is Preventicus a public or private company?
Preventicus is a private company.
What is the current stock price of Preventicus?
Preventicus is a private company, so its shares have no public market price. Caplight tracks Preventicus's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Preventicus worth (valuation)?
Valuation information for Preventicus is not publicly available.
Can I buy Preventicus stock?
Preventicus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Preventicus's last funding round?
Preventicus's most recent funding round was Early Funding on December 15, 2020.
Who are the main investors in Preventicus?
Key investors in Preventicus include Privegest SA, European Commission.
Will Preventicus IPO soon?
No public IPO plans have been announced for Preventicus.
How can I track Preventicus secondary market activity?
Caplight tracks bids, offers, and trades in Preventicus's shares on secondary markets.